• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Angelini Pharma acquires Arvelle Therapeutics for $960 million expresspharma
    January 05, 2021
    Angelini Pharma will have the exclusive license to commercialise cenobamate in the European Union and other countries in the European Economic Area.
  • Ovid, Angelini Pharma Announce Agreement for OV101 americanpharmaceuticalreview
    July 22, 2020
    Ovid Therapeutics and Angelini Pharma announced an agreement in which Angelini Pharma will be responsible to develop, manufacture and commercialize OV101 (gaboxadol) for the potential treatment of Angelman syndrome in the European Union, other countries..
  • Angelini Pharma Acquires ThermaCare from GSK americanpharmaceuticalreview
    March 11, 2020
    Angelini Pharma has acquired the ThermaCare® global business rights, excluding North America, from GSK. The deal also includes the dedicated US manufacturing site for ThermaCare in Albany, Georgia.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service